Literature DB >> 3003088

Purification and characterization of heparin-binding endothelial cell growth factors.

R Lobb, J Sasse, R Sullivan, Y Shing, P D'Amore, J Jacobs, M Klagsbrun.   

Abstract

Thirteen endothelial cell growth factors have been purified to homogeneity by heparin affinity and reversed-phase high performance liquid chromatography, and their chromatographic and electrophoretic properties were compared. The amino acid compositions of 10 of these mitogens have also been determined. The results indicate that these heparin-binding growth factors (HBGFs) can be subdivided into two classes. Class 1 HBGFs are anionic mitogens of molecular weight 15,000-17,000 found in high levels in neural tissue and include acidic brain fibroblast growth factor and retina-derived growth factor. Class 2 HBGFs are cationic mitogens of molecular weight 18,000-20,000 found in a variety of normal tissues and are typified by pituitary fibroblast growth factor and cartilage-derived growth factor. Typical class 2 HBGFs have also been isolated from a rat chondrosarcoma, a human melanoma, and a human hepatoma, suggesting that tumors do not make a structurally distinct HBGF class. These results provide a sound basis for the evaluation of the HBGFs purified from a variety of tissues and species and for the delineation of their normal and pathological functions in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003088

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

Review 2.  Fibrin gels and their clinical and bioengineering applications.

Authors:  Paul A Janmey; Jessamine P Winer; John W Weisel
Journal:  J R Soc Interface       Date:  2009-01-06       Impact factor: 4.118

3.  Partial purification and characterization of a membrane-derived factor regulating neurotransmitter phenotypic expression.

Authors:  J E Adler; L S Schleifer; I B Black
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases.

Authors:  M Klagsbrun; S Smith; R Sullivan; Y Shing; S Davidson; J A Smith; J Sasse
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Establishment from mouse growth cartilage of clonal cell lines with responsiveness to parathyroid hormone, alkaline phosphatase activity, and ability to produce an endothelial cell growth inhibitor.

Authors:  M Takigawa; E Shirai; M Enomoto; A Kinoshita; H O Pan; F Suzuki; Y Yugari
Journal:  Calcif Tissue Int       Date:  1989-11       Impact factor: 4.333

6.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse.

Authors:  D G Greenhalgh; K H Sprugel; M J Murray; R Ross
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

7.  Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.

Authors:  M A Hull; J L Brough; D G Powe; G I Carter; D Jenkins; C J Hawkey
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  In vitro inhibition of the actions of basic FGF by a novel 16 amino acid peptide.

Authors:  I Cosic; A E Drummond; J R Underwood; M T Hearn
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

9.  Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.

Authors:  Michael Fannon; Kimberly Forsten-Williams; Matthew A Nugent; Kalvin J Gregory; Chia Lin Chu; Adrienne L Goerges-Wildt; Dipak Panigrahy; Arja Kaipainen; Carmen Barnes; Cathy Lapp; Yuen Shing
Journal:  J Cell Physiol       Date:  2008-05       Impact factor: 6.384

10.  Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate.

Authors:  A G Gambarini; C A Miyamoto; G A Lima; H B Nader; C P Dietrich
Journal:  Mol Cell Biochem       Date:  1993-07-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.